{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T05:26:10Z","timestamp":1782969970250,"version":"3.54.5"},"reference-count":32,"publisher":"Archives of Endocrinology and Metabolism","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,9,11]]},"DOI":"10.20945\/2359-4292-2023-0391","type":"journal-article","created":{"date-parts":[[2024,10,7]],"date-time":"2024-10-07T19:47:02Z","timestamp":1728330422000},"source":"Crossref","is-referenced-by-count":4,"title":["Usefulness of prolactin levels in predicting the etiology of hyperprolactinemia in a cohort of 770 patients"],"prefix":"10.20945","volume":"68","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4815-6963","authenticated-orcid":false,"given":"Lucio","family":"Vilar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3740-4290","authenticated-orcid":false,"given":"Clarice Freitas","family":"Vilar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-4369-5137","authenticated-orcid":false,"given":"Ruy","family":"Lyra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4333-2553","authenticated-orcid":false,"given":"Luciano","family":"Albuquerque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9150-9130","authenticated-orcid":false,"given":"Ana Carolina Th\u00e9","family":"Garrido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3374-1062","authenticated-orcid":false,"given":"Patr\u00edcia Sampaio","family":"Gadelha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2147-227X","authenticated-orcid":false,"given":"Erik Trov\u00e3o","family":"Diniz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8814-701X","authenticated-orcid":false,"given":"Marcos","family":"Almeida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4664-9468","authenticated-orcid":false,"given":"Lucia Helena","family":"Cordeiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0457-2981","authenticated-orcid":false,"given":"Erico Higino de","family":"Carvalho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-2816-2711","authenticated-orcid":false,"given":"Ana Teresa Bezerra de","family":"Melo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4145-8993","authenticated-orcid":false,"given":"Karoline Matias","family":"Medeiros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8474-408X","authenticated-orcid":false,"given":"Gabriel Rodrigues de Assis","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4437-3821","authenticated-orcid":false,"suffix":"Neto","given":"Jos\u00e9 Coelho","family":"Moror\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-2219-5041","authenticated-orcid":false,"given":"Daniela Zago","family":"Ximenes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6419-1078","authenticated-orcid":false,"given":"Camila Ribeiro Coutinho","family":"Madruga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3259-550X","authenticated-orcid":false,"given":"Ros\u00e1lia de Oliveira","family":"Nunes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-9160-0800","authenticated-orcid":false,"given":"Yanna Queiroz Pereira de","family":"S\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3363-3803","authenticated-orcid":false,"given":"Luciana Ansaneli","family":"Naves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"8510","reference":[{"issue":"1","key":"key20241007194655_B1","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1159\/000499694","article-title":"Pitfalls in the diagnostic evaluation of hyperprolactinemia","volume":"109","author":"Vilar","year":"2019","unstructured":"1. Vilar L, Vilar CF, Lyra R, Freitas MDC. Pitfalls in the diagnostic evaluation of hyperprolactinemia. Neuroendocrinology. 2019;109(1):7-19. doi: 10.1159\/000499694.","journal-title":"Neuroendocrinology"},{"key":"key20241007194655_B2","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/S0889-8529(05)70203-6","article-title":"Disorders of prolactin secretion","volume":"30","author":"Molitch","year":"2001","unstructured":"2. Molitch ME. Disorders of prolactin secretion. Endocrinol Metab Clin North Am. 2001;30:585-610. doi: 10.1016\/s0889-8529(05)70203-6.","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"2","key":"key20241007194655_B3","doi-asserted-by":"crossref","first-page":"236","DOI":"10.20945\/2359-3997000000032","article-title":"Controversial issues in the management of hyperprolactinemia and prolactinomas - An overview by the Neuroendocrinology Department of the Brazilian Society of Endocrinology and Metabolism","volume":"62","author":"Vilar","year":"2018","unstructured":"3. Vilar L, Abucham J, Albuquerque JL, Araujo LA, Azevedo MF, Boguszewski CL, et al. Controversial issues in the management of hyperprolactinemia and prolactinomas - An overview by the Neuroendocrinology Department of the Brazilian Society of Endocrinology and Metabolism. Arch Endocrinol Metab. 2018;62(2):236-63. doi: 10.20945\/2359-3997000000032","journal-title":"Arch Endocrinol Metab"},{"issue":"7","key":"key20241007194655_B4","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1210\/jc.2011-2976","article-title":"Approach to the patient with persistent hyperprolactinemia and negative sellar imaging","volume":"97","author":"Glezer","year":"2012","unstructured":"4. Glezer A, Bronstein MD. Approach to the patient with persistent hyperprolactinemia and negative sellar imaging. J Clin Endocrinol Metab. 2012;97(7):2211-6. doi: 10.1210\/jc.2011-2976.","journal-title":"J Clin Endocrinol Metab"},{"key":"key20241007194655_B5","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/B978-1-4160-5583-9.00018-6","volume-title":"Endocrinology","author":"Bronstein","year":"2010","unstructured":"5. Bronstein MD. Disorders of prolactin secretion and prolactinomas. In: DeGroot LJ, Jameson JL, editors. Endocrinology. 6th ed. Philadelphia: Saunders\/Elsevier; 2010. p. 333-57.","edition":"6th"},{"issue":"3","key":"key20241007194655_B6","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1210\/edrv-16-3-354","article-title":"Structural variants of prolactin: occurrence and physiological significance","volume":"16","author":"Sinha","year":"1995","unstructured":"6. Sinha YN. Structural variants of prolactin: occurrence and physiological significance. Endocr Rev. 1995;16(3):354-69. doi: 10.1210\/edrv-16-3-354.","journal-title":"Endocr Rev"},{"issue":"2","key":"key20241007194655_B7","doi-asserted-by":"crossref","first-page":"171","DOI":"10.11613\/BM.2012.020","article-title":"Macroprolactinemia: new insights in hyperprolactinemia","volume":"22","author":"Kasum","year":"2012","unstructured":"7. Kasum M, Oreskovic S, Zec I, Jezek D, Tomic V, Gall V, et al. Macroprolactinemia: new insights in hyperprolactinemia. Biochem Med (Zagreb). 2012;22(2):171-9. doi: 10.11613\/bm.2012.020","journal-title":"Biochem Med (Zagreb)"},{"issue":"7","key":"key20241007194655_B8","doi-asserted-by":"crossref","first-page":"3927","DOI":"10.1210\/jc.2004-2234","article-title":"The impact on clinical practice of routine screening for macroprolactin","volume":"90","author":"Gibney","year":"2005","unstructured":"8. Gibney J, Smith TP, McKenna TJ. The impact on clinical practice of routine screening for macroprolactin. J Clin Endocrinol Metab. 2005;90 (7):3927-32. doi: 10.1210\/jc.2004-2234","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"key20241007194655_B9","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1210\/jcem.87.2.8272","article-title":"Macroprolactinemia revisited: a study on 106 patients","volume":"87","author":"Vallette-Kasic","year":"2002","unstructured":"9. Vallette-Kasic S, Morange-Ramos I, Selim A, Gunz G, Morange S, Enjalbert A, et al. Macroprolactinemia revisited: a study on 106 patients. J Clin Endocrinol Metab. 2002;87(2):581-8. doi: 10.1210\/jcem.87.2.8272","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"key20241007194655_B10","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1111\/j.1365-2362.2007.01823.x","article-title":"Patients with macroprolactinaemia: clinical and radiological features","volume":"37","author":"Donadio","year":"2007","unstructured":"10. Donadio F, Barbieri A, Angioni R, Mantovani G, Beck-Peccoz P, Spada A, et al. Patients with macroprolactinaemia: clinical and radiological features. Eur J Clin Invest. 2007;37(7):552-7. doi: 10.1111\/j.1365-2362.2007.01823.x.","journal-title":"Eur J Clin Invest"},{"issue":"3","key":"key20241007194655_B11","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1210\/jc.2005-1831","article-title":"Human macroprolactin displays low biological activity via its homologous receptor in a new sensitive bioassay","volume":"91","author":"Glezer","year":"2006","unstructured":"11. Glezer A, Soares CRJ, Vieira JG, Giannella-Neto D, Ribela MTCP, Goffin V, et al. Human macroprolactin displays low biological activity via its homologous receptor in a new sensitive bioassay. J Clin Endocrinol Metab. 2006;91(3):1048-55. doi: 10.1210\/jc.2005-1831","journal-title":"J Clin Endocrinol Metab"},{"key":"key20241007194655_B12","doi-asserted-by":"crossref","DOI":"10.1038\/s41574-023-00886-5","article-title":"Diagnosis and management of prolactin-secreting pituitary adenomas: a Pituitary Society international Consensus Statement","author":"Petersenn","year":"2023","unstructured":"12. Petersenn S, Fleseriu M, Casanueva FF, Giustina A, Biermasz N, Biller BMK, et al. Diagnosis and management of prolactin-secreting pituitary adenomas: a Pituitary Society international Consensus Statement. Nat Rev Endocrinol. 2023 Sep 5. doi: 10.1038\/s41574-023-00886-5.","journal-title":"Nat Rev Endocrinol"},{"issue":"5","key":"key20241007194655_B13","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1007\/BF03346388","article-title":"Diagnosis and management of hyperprolactinemia: results of a Brazilian multicenter study with 1234 patients","volume":"31","author":"Vilar","year":"2008","unstructured":"13. Vilar L, Freitas MC, Naves LA, Casulari LA, Azevedo M, Montenegro R Jr, et al. Diagnosis and management of hyperprolactinemia: results of a Brazilian multicenter study with 1234 patients. J Endocrinol Invest. 2008;31(5):436-44. doi: 10.1007\/BF03346388","journal-title":"J Endocrinol Invest"},{"issue":"2","key":"key20241007194655_B14","first-page":"79","article-title":"Clinical and laboratory features greatly overlap in patients with macroprolactinemia or monomeric hyperprolactinemia","volume":"32","author":"Vilar","year":"2007","unstructured":"14. Vilar L, Naves LA, Freitas MC, Lima M, Canadas V, Albuquerque JL, et al. Clinical and laboratory features greatly overlap in patients with macroprolactinemia or monomeric hyperprolactinemia. Minerva Endocrinol. 2007;32(2):79-86.","journal-title":"Minerva Endocrinol"},{"key":"key20241007194655_B15","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/167132","article-title":"Macroprolactinemia: diagnostic, clinical, and pathogenic significance","volume":"2012","author":"Shimatsu","year":"2012","unstructured":"15. Shimatsu A, Hattori N. Macroprolactinemia: diagnostic, clinical, and pathogenic significance. Clin Dev Immunol. 2012;2012:167132. doi: 10.1155\/2012\/167132","journal-title":"Clin Dev Immunol"},{"issue":"5","key":"key20241007194655_B16","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.beem.2009.05.003","article-title":"Pituitary tumours: the prolactinoma","volume":"23","author":"Colao","year":"2009","unstructured":"16. Colao A. Pituitary tumours: the prolactinoma. Best Pract Res Clin Endocrinol Metab. 2009;23(5):575-96. doi: 10.1016\/j.beem.2009.05.003","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"key20241007194655_B17","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1159\/000262537","article-title":"Pituitary tumors: advances in neuroimaging","volume":"17","author":"Morana","year":"2010","unstructured":"17. Morana G, Maghnie M, Rossi A. Pituitary tumors: advances in neuroimaging. Endocr Dev. 2010;17:160-74. doi: 10.1159\/000262537.","journal-title":"Endocr Dev"},{"issue":"1","key":"key20241007194655_B18","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1590\/0004-2730000003002","article-title":"Challenges and pitfalls in the diagnosis of hyperprolactinemia","volume":"58","author":"Vilar","year":"2014","unstructured":"18. Vilar L, Fleseriu F, Bronstein MD. Challenges and pitfalls in the diagnosis of hyperprolactinemia. Arq Bras Endocrinol Metabol. 2014;58(1):9-22. doi: 10.1590\/0004-2730000003002","journal-title":"Arq Bras Endocrinol Metabol"},{"issue":"41","key":"key20241007194655_B19","article-title":"Hyperprolactinemia in clinical non-functional pituitary macroadenomas","volume":"99","author":"Liang","year":"2020","unstructured":"19. Liang L, Senlin Y, Yu H, Cheng C, Yong J, Yang Y, et al. Hyperprolactinemia in clinical non-functional pituitary macroadenomas. Medicine. 2020;99(41):e22673. doi: 10.1097\/MD.0000000000022673","journal-title":"Medicine"},{"issue":"7","key":"key20241007194655_B20","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.endinu.2017.05.009","article-title":"Clinically non-functioning pituitary adenomas: Pathogenic, diagnostic and therapeutic aspects","volume":"64","author":"Mercado","year":"2017","unstructured":"20. Mercado M, Melgar V, Salame L, Cuenca D. Clinically non-functioning pituitary adenomas: Pathogenic, diagnostic and therapeutic aspects. Endocrinol Diabetes Nutr. 2017;64(7):384-95. doi: 10.1016\/j.endinu.2017.05.009","journal-title":"Endocrinol Diabetes Nutr"},{"issue":"4","key":"key20241007194655_B21","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1111\/j.1365-2265.2006.02627.x","article-title":"Do the limits of serum prolactin in disconnection hyperprolactinaemia need re-definition? A study of 226 patients with histologically verified non-functioning pituitary macroadenoma","volume":"65","author":"Karavitaki","year":"2006","unstructured":"21. Karavitaki N, Thanabalasingham G, Shore HC, Trifanescu R, Ansorge O, Meston N, et al. Do the limits of serum prolactin in disconnection hyperprolactinaemia need re-definition? A study of 226 patients with histologically verified non-functioning pituitary macroadenoma. Clin Endocrinol (Oxf). 2006;65(4):524-9. doi: 10.1111\/j.1365-2265.2006.02627.x.","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"7","key":"key20241007194655_B22","first-page":"508","article-title":"Serum prolactin concentration at presentation of non-functioning pituitary macroadenomas","volume":"36","author":"Behan","year":"2013","unstructured":"22. Behan LA, O'Sullivan EP, Glynn N, Woods C, Crowley RK, Tun TK, et al. Serum prolactin concentration at presentation of non-functioning pituitary macroadenomas. J Endocrinol Invest. 2013;36(7):508-14. doi: 10.3275\/8815","journal-title":"J Endocrinol Invest"},{"issue":"1","key":"key20241007194655_B23","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1159\/000495184","article-title":"Giant Prolactinomas","volume":"109","author":"Shimon","year":"2019","unstructured":"23. Shimon I. Giant Prolactinomas. Neuroendocrinology. 2019;109(1):51-56. doi: 10.1159\/000495184","journal-title":"Neuroendocrinology"},{"issue":"4","key":"key20241007194655_B24","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1111\/cen.12242","article-title":"Giant prolactinomas: the therapeutic approach","volume":"79","author":"Moraes","year":"2013","unstructured":"24. Moraes AB, Silva CM, Vieira Neto L, Gadelha MR. Giant prolactinomas: the therapeutic approach. Clin Endocrinol (Oxf). 2013;79(4):447-56. doi: 10.1111\/cen.12242","journal-title":"Clin Endocrinol (Oxf)"},{"key":"key20241007194655_B25","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1242588","article-title":"The clinical and therapeutic profiles of prolactinomas associated with germline pathogenic variants in the aryl hydrocarbon receptor interacting protein (AIP) gene","volume":"14","author":"Vroonen","year":"2023","unstructured":"25. Vroonen L, Beckers A, Camby S, Cuny T, Beckers P, Jaffrain-Rea ML, et al. The clinical and therapeutic profiles of prolactinomas associated with germline pathogenic variants in the aryl hydrocarbon receptor interacting protein (AIP) gene. Front Endocrinol (Lausanne). 2023;14:1242588. doi: 10.3389\/fendo.2023.1242588","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"key20241007194655_B26","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s11060-005-9108-7","article-title":"Giant invasive pituitary prolactinoma with falsely low serum prolactin: the significance of 'hook effect'","volume":"79","author":"Fleseriu","year":"2006","unstructured":"26. Fleseriu M, Lee M, Pineyro MM, Skugor M, Reddy SK, Siraj ES, et al. Giant invasive pituitary prolactinoma with falsely low serum prolactin: the significance of 'hook effect'. J Neurooncol. 2006;79(1):41-3. doi: 10.1007\/s11060-005-9108-7","journal-title":"J Neurooncol"},{"issue":"4","key":"key20241007194655_B27","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s11102-018-0888-0","article-title":"Management of cystic prolactinomas: a review","volume":"21","author":"Nakhleh","year":"2018","unstructured":"27. Nakhleh A, Shehadeh N, Hochberg I, Zloczower M, Zolotov S, Taher R, et al. Management of cystic prolactinomas: a review.Pituitary. 2018;21(4):425-30. doi: 10.1007\/s11102-018-0888-0","journal-title":"Pituitary"},{"key":"key20241007194655_B28","year":"2019","unstructured":"28. Prolactin on elecsys and modular analytics E801. [Package insert]. 2019-01, V 1.0, Indianapolis, IN: Roche Diagnostics.","journal-title":"Prolactin on elecsys and modular analytics E801"},{"issue":"4","key":"key20241007194655_B29","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1007\/s11102-022-01246-8","article-title":"Prolactin immunoassay: does the high-dose hook effect still exist?","volume":"25","author":"Raverot","year":"2022","unstructured":"29. Raverot V, Perrin P, Chanson P, Jouanneau E, Brue T, Raverot G. Prolactin immunoassay: does the high-dose hook effect still exist? Pituitary. 2022;25(4):653-7. doi: 10.1007\/s11102-022-01246-8","journal-title":"Pituitary"},{"issue":"21","key":"key20241007194655_B30","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph17218199","article-title":"Global prevalence of macroprolactinemia among patients with hyperprolactinemia: a systematic review and meta-analysis","volume":"17","author":"Che Soh","year":"2020","unstructured":"30. Che Soh NAA, Yaacob NM, Omar J, Mohammed Jelani A, Shafii N, Tuan Ismail TS, et al. Global prevalence of macroprolactinemia among patients with hyperprolactinemia: a systematic review and meta-analysis. Int J Environ Res Public Health. 2020;17(21):819. doi: 10.3390\/ijerph17218199","journal-title":"Int J Environ Res Public Health"},{"issue":"2","key":"key20241007194655_B31","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1210\/jc.2010-1692","article-title":"Diagnosis and treatment of hyperprolactinemia: an Endocrine Society clinical practice guideline","volume":"96","author":"Melmed","year":"2011","unstructured":"31. Melmed S, Casanueva FF, Hoffman AR, Kleinberg DL, Montori VM, Schlechte JA, et al. Diagnosis and treatment of hyperprolactinemia: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011;96(2):273-88. doi: 10.1210\/jc.2010-1692","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"key20241007194655_B32","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s12020-011-9576-9","article-title":"Clinical and radiological findings in macroprolactinemia","volume":"41","author":"sik","year":"2012","unstructured":"32. sik S, Berker D, Tutuncu YA, Ozuguz U, Gokay F, Erden G, et al. Clinical and radiological findings in macroprolactinemia. Endocrine. 2012;41(2):327-33. doi: 10.1007\/s12020-011-9576-9.","journal-title":"Endocrine"}],"container-title":["Archives of Endocrinology and Metabolism"],"original-title":[],"language":"en","deposited":{"date-parts":[[2024,10,7]],"date-time":"2024-10-07T19:47:13Z","timestamp":1728330433000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aem-sbem.com\/article\/usefulness-of-prolactin-levels-in-predicting-the-etiology-of-hyperprolactinemia-in-a-cohort-of-770-patients\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"references-count":32,"alternative-id":["10.20945\/2359-4292-2023-0391"],"URL":"https:\/\/doi.org\/10.20945\/2359-4292-2023-0391","relation":{},"ISSN":["2359-3997","2359-4292"],"issn-type":[{"value":"2359-3997","type":"print"},{"value":"2359-4292","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024]]},"article-number":"e230391"}}